Determination of S-1 (combined drug of tegafur, 5-chloro-2,4-dihydroxypyridine and potassium oxonate) and 5-fluorouracil in human plasma and urine using high-performance liquid chromatography and gas chromatography-negative ion chemical ionization mass sp
スポンサーリンク
概要
- 論文の詳細を見る
- 1997-03-28
著者
-
Yoshida Ken-ichiro
Pharmacokinetics Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
MATSUSHIMA Eiji
Pharmacokinetics Research Laboratory, Taiho Pharmaceutical Co. Ltd.
-
YOSHIDA Kozo
Pharmacokinetics Research Laboratory, Taiho Pharmaceutical Co. Ltd.
-
KITAMURA Ryuichi
Pharmacokinetics Research Laboratory, Taiho Pharmaceutical Co. Ltd.
-
Matsushima Eiji
Pharmacokinetics Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Yoshida Kozo
Pharmacokinetics Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Kitamura Ryuichi
Pharmacokinetics Research Laboratory Taiho Pharmaceutical Co. Ltd.
関連論文
- Determination of S-1 (combined drug of tegafur, 5-chloro-2,4-dihydroxypyridine and potassium oxonate) and 5-fluorouracil in human plasma and urine using high-performance liquid chromatography and gas chromatography-negative ion chemical ionization mass sp
- 新規血管新生阻害剤TSU-68のラットにおける早期の自己誘導
- Determination of a new podophyllotoxin derivative, TOP-53, and its metabolite in rat plasma and urine by high-performance liquid chromatography with electrochemical detection
- Estimation of optimal dose of propiverine hydrochloride, in pediatric population suffering from overactive bladder
- Validation of a simple liquid chromatography-tandem mass spectrometric method for the determination of propiverine hydrochloride and its N-oxide metabolite in human plasma
- Improvement in precision of the liquid chromatographic-electrospray ionization tandem mass spectrometric analysis of 3'-C-ethynylcytidine in rat plasma